Back to News
Market Impact: 0.28
Thursday's ETF Movers: ARKG, SIXA
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
The ARK Genomic Revolution ETF rose about 8.5% in Thursday trading, outperforming other ETFs. Key holdings Absci and Schrodinger gained approximately 18.9% and 17.3%, respectively, driving strong performance in genomics and biotech-linked equities.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
ABSI0.62
SDGR0.58
More News
- Asian stocks rise as oil retreat eases inflation fears, BOJ in focus
- Kevin Warsh, an angry Trump and Jerome Powell Déjà vu: how history is repeating itself
- A breakout in the 10-year Treasury yield could hold back stocks if it reaches this level
- Fed rate decision and Warsh comments roiled markets. Where to find opportunities
- Biweekly Investment Insights: Markets swirl
- Analysis-Fed builds credibility, but hawkish turn leaves investors edgy